Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S2W-21271 · Session 2

Further to the answer to question S2W-20285 by Mr Andy Kerr on 10 November 2005, whether the decisions of the Medicines and Healthcare prod…

Answered Asked by Alex Neil SNP Lodged 30 Nov 2005

The question

To ask the Scottish Executive, further to the answer to question S2W-20285 by Mr Andy Kerr on 10 November 2005, whether the decisions of the Medicines and Healthcare products Regulatory Agency or the European Medicines Agency are binding on the Executive and the NHS in Scotland.

The answer

Answered by Andy Kerr on 12 Dec 2005 · 12 days after it was lodged, on time

Before a medicine can be placed on the UK market it must have a marketing authorisation either from the Medicines and Healthcare products Regulatory Agency or the European Medicines Agency. Decisions on the marketing authorisations of medicines made by the MHRA or the EMEA are binding on the Executive and the NHS in Scotland.
Information about the MHRA and its work can be found at www.mhra.gov.uk.

In the Official Report

No contribution in the Official Report cites S2W-21271 by reference.